EU_Renal_Contents.qxp 28/2/08 11:40 Page 3
Contents
Effect of Long-term Epoetin Treatment on Serum Levels of High-density
Lipoprotein (HDL) and HDL-associated Enzymes in Patients with
Chronic Kidney Disease 34
Alexandros D Tselepis
1
and Kostas C Siamopoulos
2
1. Professor of Biochemistry/Clinical Chemistry, Department of Biochemistry, University of Ioannina;
2. Professor of Medicine/Nephrology, Department of Internal Medicine, University of Ioannina
Nutrition and Hypoalbuminuria
The Ability of Albumin to Predict Outcome in Haemodialysis Patients 37
Kamyar Kalantar-Zadeh
Associate Professor of Medicine and Paediatrics and Epidemiology, David Geffen School of Medicine,
University of California at Los Angeles (UCLA), and Director of Off-Campus Dialysis Expansion and
Epidemiology, Division of Nephrology and Hypertension, Harbor-UCLA
Dietary Protein Restriction in the Management of Chronic
Kidney Disease 41
Uday M Khosla
1
and William E Mitch
2
1. Assistant Professor of Medicine; 2. Gordon A Cain Chair in Nephrology, and Director, Division of
Nephrology, Baylor College of Medicine
Effect of Growth Hormone on Biomarkers of Nutrition and
Cardiovascular Disease as well as on Quality of Life in Patients on
Chronic Maintenance Haemodialysis 46
Bo Feldt-Rasmussen
Chief, Division of Nephrology, Rigshospitalet, University of Copenhagen
Cardiovascular Risk
Cardiovascular Risk in Patients with Chronic Kidney Disease 49
Ernesto Paoletti
Assistant Professor of Nephrology, Nephrology, Dialysis and Transplantation Unit, Hospital S Martino
Ambulatory Blood Pressure Measurement Should Be a
Routine Investigation in Patients with Renal Disease 52
Eoin O’Brien
Professor of Molecular Pharmacology, Conway Institute of Biomolecular and Biomedical Research,
University College Dublin
Dialysis
Haemodiafiltration – The New Gold Standard? 54
Claudio Ronco,
1
Mikko Haapio
2
and Dinna Cruz
1
1. Department of Nephrology, St Bortolo Hospital, Vicenza; 2. Division of Nephrology, Helsinki
University Central Hospital
The Status of Peritoneal Dialysis in Europe – An Update 58
Norbert Lameire
Emeritus Professor of Medicine, Renal Division, University Hospital, Ghent
Transplantation
Targeting B Cells with Rituximab – A Novel Therapy for
Renal Disease and Transplantation 62
Alan D Salama
Senior Lecturer and Honorary Consultant Physician, Renal Section, Division of Medicine,
Imperial College London and Hammersmith Hospital
Current Trends in Immunosuppressive Strategies After Renal Transplantation 66
Charles Newstead
Consultant Renal Physician, St James’s Hospital, Leeds
Immunosuppressive Drugs After Renal Transplant 70
Antonio Dal Canton and Ciro Esposito
Unit of Nephrology, University of Pavia School of Medicine
EUROPEAN RENAL DISEASE 2007 3
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76